A center to train students to work in cancer research, as well as invent new tests to determine the exact proteins responsible for cancers in specific patients, is planned to be up and running at the University of Massachusetts in Boston by this fall.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
